نتایج جستجو برای: immune mediated thrombocytopenia

تعداد نتایج: 656572  

Journal: :iranian journal of blood and cancer 0
eshghi p malek f madani f esfahani h

treatment of severe immune thrombocytopenic purpura (itp) accompanied by life-threatening bleeding events is challenging and a combination of treatment measures should be undertaken to rapidly increase the platelet count. herein, we report a case of severe itp in a seven-year-old boy who suffered from massive bleeding which was totally unresponsive to conventional therapeutic interventions. sin...

Journal: :journal of cellular and molecular anesthesia 0
alireza jahangirifard assistant professor of anesthesiology, fellowship of cardiac anesthesia, tracheal diseases research center, national research institute of tuberculosis and lung diseases (nritld), shahid beheshti university of medical science, tehran, iran majid golestani eraghi anesthesiologist, fellowship in intensive care, chronic respiratory diseases research cenetr, shahid beheshti university of medical science, tehran, iran mohammad ali saghafi resident of anesthesiology, anesthesiology research cenetr, shahid beheshti university of medical science, tehran, iran

heparin- induced thrombocytopenia (hit) is an antibody mediated adverse effect of heparin therapy which is classified into two subtypes, hit i which is non-immune, spontaneously reversible thrombocytopenia and; hit ii which is an autoimmune-mediated adverse effect of heparin therapy. in this case report, we described a 65-year old male patient with hit ii after coronary artery bypass grafting. ...

Journal: :iranian journal of pharmaceutical research 0
ramin shekarriz md, board certified hematologist-oncologist, assistant professor, department of hematology-oncology, cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran neda koulaeinejad pharmd, resident of clinical pharmacy, faculty of pharmacy, mazandaran university of medical sciences, sari, iran anahita nosrati md, board certified pathologist, assistant professor, department of pathology, imam khomeini hospital, mazandaran university of medical sciences, sari, iran ebrahim salehifar pharmd, board certified clinical pharmacist, associated professor, department of clinical pharmacy, pharmaceutical research center, mazandaran university of medical sciences, sari, iran

sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. it was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. it has several adverse reactions on multi organ systems including hematologic system. although the neutropenia and thrombocytopenia commonly happens as gra...

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

Journal: :Veterinary Quarterly 1998

Esfahani H, Eshghi P, Madani F, Malek F,

Treatment of severe Immune Thrombocytopenic purpura (ITP) accompanied by life-threatening bleeding events is challenging and a combination of treatment measures should be undertaken to rapidly increase the platelet count. Herein, we report a case of severe ITP in a seven-year-old boy who suffered from massive bleeding which was totally unresponsive to conventional therapeutic interventions. Sin...

Journal: :iranian journal of blood and cancer 0
nematollah rostami soheila borhani mahyar khaledi zohreh maghsoomi

background: immune thrombocytopenia is a hematologic disorder characterized by low platelet count and variable bleeding manifestations due to immune-mediated platelet destruction and/or suppression of platelet production. this study was performed to evaluate characteristics and clinical presentations of adult patients with immune thrombocytopenia and to explore the clinical value of platelet an...

Mahyar Khaledi, Nematollah Rostami, Soheila Borhani, Zohreh Maghsoomi,

Background: Immune thrombocytopenia is a hematologic disorder characterized by low platelet count and variable bleeding manifestations due to immune-mediated platelet destruction and/or suppression of platelet production. This study was performed to evaluate characteristics and clinical presentations of adult patients with immune thrombocytopenia and to explore the clinical value of platelet an...

G. N. Kim J. H. Kim, S. M. Kim S. W. Jeong

Background: Splenic infarction (SI) is a rare clinical entity seldom encountered in veterinary medicine. Its most frequent causes include thromboembolic status, splenomegaly, and cardiac disease. Although thrombotic elements from the circulation provide the most common context for thromboembolic SIs, immune-mediated hemolytic anemia (IMHA) has not been reported as an underlying...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید